Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2018-03-22 AGM Information
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
NeuroVive Pharmaceutical AB (publ): kommuniké från extra bolagsstämma
AGM Information Classification · 1% confidence The document is titled "NeuroVive Pharmaceutical AB (publ): kommuniké från extra bolagsstämma" (communication from the Extraordinary General Meeting). It details the resolutions passed at this meeting, specifically concerning a rights issue (nyemission) of shares and warrants, changes to the articles of association (bolagsordningen), and granting authorization to the board for future issuances. These resolutions are the direct outcomes of a shareholder vote at a general meeting. While it relates to capital changes (CAP) and governance (CGR), the primary context is the formal communication of decisions made at a shareholder meeting. The closest fit among the provided codes is 'AGM-R' (AGM Information), as an Extraordinary General Meeting (EGM) functions similarly to an AGM in terms of shareholder decision-making, and this document summarizes those decisions. However, since the document explicitly details voting results and decisions made at a general meeting, 'DVA' (Declaration of Voting Results & Voting Rights Announcements) is also highly relevant, but 'AGM-R' covers the general meeting context better, even if it's an EGM. Given the content is the *summary of decisions* from the meeting itself, AGM-R is the most appropriate classification for meeting materials/outcomes, although DVA is a strong secondary candidate if the focus were strictly on the vote tally. Since it's a summary of the meeting's actions, AGM-R is selected.
2018-03-22 Swedish
NeuroVive Pharmaceutical AB (publ): report from EGM
Capital/Financing Update Classification · 1% confidence The document is titled 'NeuroVive Pharmaceutical AB (publ): report from EGM' and details resolutions passed at an Extraordinary General Meeting (EGM) held on March 22, 2018. The primary resolutions concern the approval of a Rights Issue (issuing shares and warrants) and amendments to the articles of association to facilitate this capital change. This content directly relates to capital structure changes and shareholder voting outcomes, but the core event is the EGM itself and the resulting decisions on share issuance. Since the document reports the results of a shareholder vote (EGM resolutions) and specifically details a major capital change (Rights Issue), it strongly aligns with 'Capital/Financing Update' (CAP) due to the focus on issuing shares/warrants, and 'Declaration of Voting Results & Voting Rights Announcements' (DVA) due to reporting EGM outcomes. However, the most specific action described is the approval of the Rights Issue, which is a financing activity. Given the detailed breakdown of the share/warrant issuance terms, CAP is highly relevant. Since it is a report *from* the EGM detailing the resolutions, and the resolutions are primarily about capital structure, I will prioritize CAP, but DVA is also a strong candidate. Since the document is a report *of* the meeting and its resolutions, and the resolutions are about capital, CAP is the best fit for the financial action taken. If the document were only the voting results without the financial details, DVA would be better. Given the extensive financial terms, CAP is selected.
2018-03-22 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding where the holder, Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension, crossed a threshold, resulting in a new holding percentage of 10.04%. The table explicitly mentions 'Reason for major shareholding notification Buy' and provides detailed 'Before the transaction' and 'After the transaction' data regarding shares and voting rights. This structure perfectly matches the definition of a Major Shareholding Notification (MRQ). The document length is short (3549 chars), but the content is the notification itself, not an announcement of a report.
2018-03-07 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the period January-December 2017. It contains detailed financial statements (income statements, earnings per share), management commentary, and operational updates. It is a comprehensive financial report for a period shorter than a full fiscal year (or in this case, the final quarterly/annual summary report), which fits the definition of an Interim/Quarterly Report (IR) in the provided schema, as it provides substantive financial data and analysis. Q4 2017
2018-02-20 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Year End Report' for the period January-December 2017. It contains detailed financial information (revenues, loss before tax, loss per share), a CEO review, and a comprehensive overview of business operations and project status. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It is not a full 10-K (which is a specific US regulatory filing), but rather an 'Interim/Quarterly Report' equivalent for a full-year period, which falls under the 'IR' category for comprehensive financial reporting for periods shorter than or equal to a fiscal year. Q4 2017
2018-02-20 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage by a specific holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') involving a 'Sell' transaction, resulting in the holding falling below the 10% threshold. This structure—reporting 'Before the transaction' and 'After the transaction' figures for shares and voting rights, and explicitly mentioning 'Reason for major shareholding notification'—is characteristic of a notification regarding a change in significant share ownership. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2018-02-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.